07. What is dronedarone (Multaq®)?

Dronedarone (brand name Multaq®) is an investigational compound developed by sanofi-aventis for the reduction in risk of cardiovascular hospitalisation or death in patients with atrial fibrillation/atrial flutter or with history of atrial fibrillation/atrial flutter. Dronedarone blocks calcium, potassium and sodium channels and has antiadrenergic effects and does not contain iodine.